[Determining asthma treatment in children by monitoring fractional exhaled nitric oxide, sputum eosinophils and leukotriene B₄]

An Pediatr (Barc). 2015 Jan;82(1):e21-5. doi: 10.1016/j.anpedi.2014.03.012. Epub 2014 May 22.
[Article in Spanish]

Abstract

Sputum eosinophils and exhaled fractional nitric oxide (FENO) are markers of airway inflammation in asthma. Cytokines, cysteinyl-leukotrienes and leukotriene B4 (LTB4) are responsible for this inflammation. The aim of this study is to determine the usefulness of these markers in monitoring asthma treatment in children. FENO, sputum eosinophils, and LTB4 in induced sputum were performed in 10 children (9-15 years old). These determinations were repeated four months later, after the beginning or an increase in the treatment. FENO values tended to decrease (P=.15), pulmonary function tended to improve (P=.10), and sputum eosinophils decreased (P=.003) compared to the first determination. There were no differences in LTB4 concentrations (P=.88). Sputum eosinophils seem to be more precise than FENO in the monitoring of inflammation in asthmatic children.

Keywords: Asma; Asthma; Children; Eosinófilos en esputo; Exhaled fractional nitric oxide; Fracción exhalada de óxido nítrico; Leucotrieno B4; Leukotriene B(4); Niños; Sputum eosinophils.

MeSH terms

  • Adolescent
  • Asthma / drug therapy*
  • Asthma / immunology
  • Breath Tests
  • Child
  • Eosinophils*
  • Humans
  • Leukocyte Count
  • Leukotriene B4 / analysis*
  • Monitoring, Physiologic
  • Nitric Oxide / analysis*
  • Prospective Studies
  • Sputum / chemistry*
  • Sputum / cytology*

Substances

  • Leukotriene B4
  • Nitric Oxide